Product range includes BPC-157, available as a standalone peptide or in a blended formulation: (1) M.J.Hsieh et al (2016) Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation Journal of Molecular Medicine, 15 November 2016, Volume 95, pages 323333
PlexusDx's Precision Peptide Genetic Test reveals predispositions in GLP1R, GIPR, FTO, and MC4R pathways, which may support conversations about medication selection
Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A et al
Peptidomimetic glutathione analogues as novel gammaGT stable GST inhibitors
Temporary Tenderness Some patients notice mild soreness or sensitivity for a short time after the injection, particularly when the same general area is used frequently
The most significant changes to body composition typically become apparent from months three to six and beyond